Discontinuation of Participation on the JSC. aTyr’s membership in the JSC (or any subcommittee established by it) will be at its sole discretion, as a matter of right and not obligation, for the sole purpose of participation in governance, decision-making, and information exchange with respect to activities within the jurisdiction of the JSC. aTyr will have the right to withdraw, at any time, from membership on the JSC (or any subcommittee) upon thirty (30) days’ prior written notice to Kyorin, which notice will be effective upon the expiration of such thirty (30) day period. Following the issuance of such notice: # aTyr’s membership in the JSC (or any subcommittee) will be terminated; and # each Party will have the obligation to continue to provide and the right to continue to receive the information it would otherwise be required to provide and entitled to receive under this Agreement and to participate directly with the other Party in discussions, reviews and approvals currently allocated to the JSC pursuant to this Section 2. If, at any time following issuance of such a notice, aTyr wishes to resume participation in the JSC, aTyr will notify Kyorin in writing and, thereafter, aTyr’s representatives to the JSC (or any subcommittee) will be entitled to attend any subsequent meeting of the JSC (or any subcommittee) and to participate in the activities of, and decision-making by, the JSC (or any subcommittee) as provided in this Section 2 as if such notice had not been issued by aTyr pursuant to this [Section 2.5]. If the JSC is disbanded, then any data and information of the nature intended to be shared within the JSC will be provided by each Party directly to the other Party.

Discontinuation. The JSC, JDC and any subcommittee or Working Group, as applicable, will disband, or if it is still in place for other Programs, shall have no further authority hereunder with respect to Licensed Products Directed Against a Target upon the first approval of an MAA for a Licensed Product Directed Against such Target in the Territory (for clarity, the Licensed Products are outside of the scope of the JCC’s authority during the entirety of the Term). Additionally, and without limiting the other provisions of this Agreement, in the event Stoke or its Affiliates acquires a Competing Product with respect to a [[Unknown Identifier]] or ​ following completion of the relevant time period in Section 2.5, the JSC and other Committees shall automatically disband as to such Target upon Stoke’s initiation of a GLP tox study for such Competing Product, and Acadia will have no further information sharing or reporting obligations to Stoke with respect thereto except for Commercialization reports as set forth in [Section 5.5(c)] and reports as set forth in [Section 5.5(c)] applied mutatis mutandis to Development activities, provided that such reports will be limited to the level of detail necessary to confirm Acadia’s financial and diligence obligations herein. With respect to a particular [[Unknown Identifier]] Co-Co Product, the JSC, JDC, JCC and any subcommittee or Working Group pertaining thereto will disband with respect to such [[Unknown Identifier]] Co-Co Product, and shall have no further authority hereunder, upon the first to occur of: # the Development Opt-Out Date; # the Commercialization Opt-Out Date; and # the end of the Term. For the avoidance of doubt, once the JSC disbands per the foregoing, Acadia shall [[Person A:Person]] have sole decision-making authority for Developing, Commercializing and all other matters for all Licensed Products for which the JSC has disbanded.

Discontinuation of Participation on a Committee. The activities to be performed by each Committee shall solely relate to governance under this Agreement, and are not intended to be or involve the delivery of services. Each Committee shall continue to exist until the first to occur of: # the Parties mutually agreeing to disband the Committee; or # [[Cytokinetics:Organization]] providing written notice to Astellas of its intention to disband and no longer participate in such Committee. Once the Parties mutually agree or [[Cytokinetics:Organization]] has provided written notice to disband such Committee, such Committee shall have no further obligations under this Agreement and, thereafter, the Alliance Managers shall be the contact persons for the exchange of information under this Agreement and decisions of such Committee shall be decisions as between the Parties, subject to the other terms and conditions of this Agreement.

Discontinuation of Participation on a Committee. For clarity, Cara’s membership in the JSC, JDC or SCC shall be at its sole discretion, as a matter of right and not obligation, for the sole purpose of participation in governance, decision-making, and information exchange with respect to activities within the jurisdiction of the Committee. Cara shall have the right to withdraw, at any time, from membership on any of the JSC, JDC or SCC upon ​ prior written notice to VFMCRP, which notice shall be effective upon the expiration of such ​ period. Following the issuance of such notice: # Cara’s membership in such committee shall be terminated and # each Party shall have the obligation to provide and the right to continue to receive the information it would otherwise be required to provide and entitled to receive under the Agreement and to participate directly with the other Party in discussions, reviews and approvals currently allocated to such committee pursuant to this Article 3. If, at any time following issuance of such a withdrawal notice, Cara wishes to resume participation in the committee, Cara shall notify VFMCRP in writing and, thereafter, Cara’s representatives to the committee shall be entitled to attend any subsequent meeting of the committee and to participate in the activities of, and decision-making by, the committee as provided in this Article 3 as if such withdrawal notice had not been issued by Cara pursuant to this [Section 3.8]. If the JSC, JDC or SCC is disbanded, then any data and information of the nature intended to be shared within such committee hereunder shall thereafter be provided by each Party directly to the other Party.

Discontinuation of Participation on a Committee. Each Committee shall continue to exist until the first to occur of # the Parties mutually agreeing to disband the Committee, or # FibroGen China providing to AstraZeneca written notice of its intention to disband and no longer participate in such Committee, which FibroGen China retains the right to do at any time during the Term, in its sole discretion; provided, however, that doing so shall not relieve FibroGen China of any of its obligations under this Agreement (save from the obligation to participate at the relevant Committee meetings). Once FibroGen China has provided written notice as referred to in subsection # above, such Committee shall have no further obligations under this Agreement and AstraZeneca shall have the right to solely decide, without consultation, any matters previously before such Committee, subject to the other terms of this Agreement.

Restrictions on Participation. Notwithstanding any provision of the Plan to the contrary, no Employee shall be granted an Option to participate in the Plan:

Discontinuation of Participation. The Joint Steering Committee (and any subcommittee established under this Article 7) shall continue to exist until the first to occur of: # the Parties mutually agreeing to disband the committee; or # Aguettant providing to AcelRx written notice of its intention to disband and no longer participate in such committee at any time during the Term. Once Aguettant has provided such written notice, Aguettant shall have no further obligations under this Agreement with respect to any such committee or subcommittee, and # any matters that would previously have been addressed by a subcommittee will be handled by the JSC, and # any matters that would previously have been addressed by the JSC will be handled by the Parties in accordance with the terms of this Agreement, except that AcelRx will have the right to decide all matters previously decided by the JSC.

Discontinuation of Participation on the JRC. Subject to [Sections 3.1.3, and 14.2.2]2], the JRC shall continue to exist until the Parties mutually agreeing to disband the JRC.

Discontinuation. In the event that Everest (including its Affiliates and their respective Sublicensees) discontinues Development or Commercialization of any Licensed Product in the Territory, then # the license of NPLH Licensed Technology to Everest under Section 2.1 (License to Everest) as to such Licensed Product shall be terminated; # Everest shall, at its expense, return all NPLH Development Data and NPLH Regulatory Documentation Portions of the exhibit, indicated by the mark “​,” were omitted and have been filed separately with the

Discontinuation of Participation on a Committee. The activities to be performed by each Committee shall solely relate to governance under this Agreement, and are not intended to be or involve the delivery of services. Each Committee shall continue to exist until the first to occur of: # the Parties mutually agreeing to disband the Committee; # Sangamo providing written notice to Kite, at any time after ​, of Sangamo’s intention to disband and no longer participate in such Committee; or # Kite providing written notice to Sangamo, at any time after ​, of Kite’s intention to disband and no longer participate in such Committee. Once a Committee is disbanded, such Committee shall have no further obligations under this Agreement and, thereafter, each Party shall designate a contact person, who may be the project manager, for the exchange of information under this Agreement and decisions of such Committee shall be decisions as between the Parties (and failure to agree shall be resolved in accordance with Section 3.4 as if such decision were a JSC decision), subject to the other terms and conditions of this Agreement.